263 related articles for article (PubMed ID: 31109698)
1. Prognostic significance of CD68
Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L
Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the infiltration of CD163
Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J
Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574
[TBL] [Abstract][Full Text] [Related]
3. Combining UBR5 and CD163
Wang C; Hong T; Wang Y; Peng G; Yu Y; Zhang J; Zhuo D; Zheng J; Ma X; Cui X
Cancer Immunol Immunother; 2021 Oct; 70(10):2925-2935. PubMed ID: 33710368
[TBL] [Abstract][Full Text] [Related]
4. Association between spatial distribution of leukocyte subsets and clinical presentation of head and neck squamous cell carcinoma.
Netzer C; von Arps-Aubert V; Mačinković I; von der Grün J; Küffer S; Ströbel P; von Knethen A; Weigert A; Beutner D
Front Immunol; 2023; 14():1240394. PubMed ID: 38322012
[TBL] [Abstract][Full Text] [Related]
5. CD163
Omilian AR; Cannioto R; Mendicino L; Stein L; Bshara W; Qin B; Bandera EV; Zeinomar N; Abrams SI; Hong CC; Yao S; Khoury T; Ambrosone CB
Breast Cancer Res; 2024 May; 26(1):75. PubMed ID: 38720366
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinical significance of tumor-associated macrophages in esophageal squamous cell carcinoma after surgery: do biomarkers and distributions matter?
Yi B; Zeng J; Li L; Zhang J; Chen Y; Gao Y
Biosci Rep; 2024 Apr; 44(4):. PubMed ID: 38501293
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinoma.
Sammarco E; Rossetti M; Salfi A; Bonato A; Viacava P; Masi G; Galli L; Faviana P
Med Oncol; 2024 May; 41(6):150. PubMed ID: 38740647
[TBL] [Abstract][Full Text] [Related]
8. DACH1 regulates macrophage activation and tumour progression in hypopharyngeal squamous cell carcinoma.
Li W; Xu L; Cao J; Ge J; Liu X; Liu P; Teng Y; Wang S; Sun Y; Liu M; Tian L
Immunology; 2023 Oct; 170(2):253-269. PubMed ID: 37243970
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of CD68, CD163 and Folate receptor-β positive macrophages in hepatocellular carcinoma.
Minami K; Hiwatashi K; Ueno S; Sakoda M; Iino S; Okumura H; Hashiguchi M; Kawasaki Y; Kurahara H; Mataki Y; Maemura K; Shinchi H; Natsugoe S
Exp Ther Med; 2018 May; 15(5):4465-4476. PubMed ID: 29731831
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma.
Asai Y; Yanagawa N; Osakabe M; Yamada N; Sugimoto R; Sato A; Ito K; Koike Y; Tanji T; Sakuraba M; Sato T; Sugai T
J Surg Oncol; 2024 Feb; 129(2):381-391. PubMed ID: 37916518
[TBL] [Abstract][Full Text] [Related]
11. STAT3 is over-activated within CD163
Andersen MN; Andersen NF; Lauridsen KL; Etzerodt A; Sorensen BS; Abildgaard N; Plesner T; Hokland M; Møller HJ
Cancer Immunol Immunother; 2022 Jan; 71(1):177-187. PubMed ID: 34061243
[TBL] [Abstract][Full Text] [Related]
12. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
Vidyarthi A; Agnihotri T; Khan N; Singh S; Tewari MK; Radotra BD; Chatterjee D; Agrewala JN
Cancer Immunol Immunother; 2019 Dec; 68(12):1995-2004. PubMed ID: 31690954
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Number Density of Tumor-Associated Macrophages by Immunohistochemistry and Semiquantitative Scoring in Invasive Breast Cancer: An Indian Study.
Bhatia JK; Malik A; Chaudhary T; Gopal A; Boruah D; Singh B
J Microsc Ultrastruct; 2023; 11(4):214-219. PubMed ID: 38213652
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of CD68+ tumor-associated macrophages in hepatocellular carcinoma: A meta-analysis.
Jin D; Qian L; Chen J; Yu Z; Dong J
Medicine (Baltimore); 2024 Apr; 103(16):e37834. PubMed ID: 38640338
[TBL] [Abstract][Full Text] [Related]
15. STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes.
Andersen MN; Etzerodt A; Graversen JH; Holthof LC; Moestrup SK; Hokland M; Møller HJ
Cancer Immunol Immunother; 2019 Mar; 68(3):489-502. PubMed ID: 30637473
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 in tumor-associated macrophages predicts a poor prognosis and promotes tumor growth in head and neck squamous cell carcinoma.
Chen L; Wan SC; Mao L; Huang CF; Bu LL; Sun ZJ
Cancer Immunol Immunother; 2023 Jun; 72(6):1647-1660. PubMed ID: 36586012
[TBL] [Abstract][Full Text] [Related]
17. CD163+ macrophage density in perimysial connective tissue associated with prognosis in IMNM.
Sun H; Wang ZY; Han Y; Wei XJ; Wang YC; Yu XF
Ann Clin Transl Neurol; 2024 May; 11(5):1267-1279. PubMed ID: 38651547
[TBL] [Abstract][Full Text] [Related]
18. SPP1
Wu J; Shen Y; Zeng G; Liang Y; Liao G
Cancer Gene Ther; 2024 Feb; 31(2):311-321. PubMed ID: 38052857
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
Bisheshar SK; De Ruiter EJ; Devriese LA; Willems SM
Oncoimmunology; 2020; 9(1):1747345. PubMed ID: 32363116
[No Abstract] [Full Text] [Related]
20. Neoadjuvant Radiochemotherapy Alters the Immune and Metabolic Microenvironment in Oral Cancer-Analyses of CD68, CD163, TGF-β1, GLUT-1 and HIF-1α Expressions.
Weber M; Ries J; Braun K; Wehrhan F; Distel L; Geppert C; Lutz R; Kesting M; Trumet L
Cells; 2024 Feb; 13(5):. PubMed ID: 38474362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
